In the gadolinium litigation, plaintiffs assert that they developed a medical condition called nephrogenic systemic fibrosis ("NSF") as a result of injection of gadolinium-based contrast agents into their veins during diagnostic medical procedures. At its April 8, 2008 Administrative Conference, the Supreme Court designated all pending and future New Jersey state court litigation involving these agents as a mass tort and has transferred all such cases to the Middlesex Vicinage for centralized case management by Judge Jamie D. Happas with the assistance of Special Master Agatha Dzikiewicz, Esq..

Privacy Policy | Contact Us | © New Jersey Judiciary